Coagulopathy and antiphospholipid antibodies in patients with Covid-19
Y Zhang, M Xiao, S Zhang, P Xia, W Cao…�- …�England Journal of�…, 2020 - Mass Medical Soc
Coagulopathy in Critical Illness with Covid-19 The authors describe a 69-year-old man with
Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill�…
Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill�…
[HTML][HTML] Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
Y Zhang, W Cao, W Jiang, M Xiao, Y Li, N Tang…�- Journal of thrombosis�…, 2020 - Springer
The outbreak of novel coronavirus disease 2019 (COVID-19) has now become a global
pandemic. Coagulopathy has been reported widely in critically ill COVID-19 patients and�…
pandemic. Coagulopathy has been reported widely in critically ill COVID-19 patients and�…
Coagulopathy associated with COVID-19
SG Lee, M Fralick, M Sholzberg�- CMAJ, 2020 - Can Med Assoc
Coagulopathy correlates with severity of COVID-19 and may include increased d-dimer
concentrations (≥ 2 times above normal range), mildly prolonged prothrombin time (~ 1–3 s�…
concentrations (≥ 2 times above normal range), mildly prolonged prothrombin time (~ 1–3 s�…
[PDF][PDF] Coagulopathy of COVID-19 and antiphospholipid antibodies
Recently in the Journal of Thrombosis and Haemostasis, Harzallah and colleagues report
the results of antiphospholipid antibody testing in a series of 56 patients with confirmed or�…
the results of antiphospholipid antibody testing in a series of 56 patients with confirmed or�…
[HTML][HTML] COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis
BE Fan, J Ng, SSW Chan, D Christopher…�- Journal of thrombosis�…, 2021 - Springer
Patients with COVID-19 are known to be at risk of developing both venous, arterial and
microvascular thrombosis, due to an excessive immuno-thrombogenic response to the�…
microvascular thrombosis, due to an excessive immuno-thrombogenic response to the�…
[HTML][HTML] Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
DRJ Arachchillage, M Laffan�- Journal of thrombosis and�…, 2020 - ncbi.nlm.nih.gov
A recently published article by Dr. Tang and colleagues on “Abnormal coagulation
parameters are associated with poor prognosis in patients with novel coronavirus�…
parameters are associated with poor prognosis in patients with novel coronavirus�…
Coagulation dysfunction: a hallmark in COVID-19
Context.—The coronavirus disease 2019 (COVID-19) is a highly contagious respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)�…
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)�…
[HTML][HTML] COVID-19-associated coagulopathy
M Franchini, G Marano, M Cruciani, C Mengoli, I Pati…�- Diagnosis, 2020 - degruyter.com
Abstract Coronavirus disease 2019 (COVID-19), a viral respiratory illness caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently�…
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been recently�…
[HTML][HTML] Altered platelet and coagulation function in moderate-to-severe COVID-19
To reveal if coagulopathies relate to the course of COVID-19, we examined 255 patients with
moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs�…
moderate and severe COVID-19, receiving anticoagulants and immunosuppressive drugs�…
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
Abstract Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in�…
coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in�…